Work

Phase 1 TITE-CRM Dose Escalation Study of Concurrent Temozolomide and Intensity Modulated Radiation Therapy in Newly Diagnosed Glioblastoma Multiforme

FWCI:
Cites:
Cited by: 3
Related to: 10